Company expects to submit New Drug Application (NDA) in April 2025 - DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton ...

Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...

Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche ...

Aveo Pharmaceuticals asserts that a stop-production notice was issued due to non-compliance with GMP standards, not for ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

"We are essentially just going in the direction that has been so successful for the pharmaceutical industry," says AgPlenus ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

ISLAMABAD: The Drug Regulatory Authority Pakistan (DRAP) has issued an immediate recall alert for a number of substandard, ...

Assetmark Inc. boosted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1,370.3% ...